BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 26398882)

  • 1. MicroRNAs involved with hepatocellular carcinoma (Review).
    Mao B; Wang G
    Oncol Rep; 2015 Dec; 34(6):2811-20. PubMed ID: 26398882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
    Gailhouste L; Ochiya T
    Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis.
    He S; Zhang DC; Wei C
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):426-34. PubMed ID: 25746139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating microRNAs as diagnostic and prognostic tools for hepatocellular carcinoma.
    Zhang YC; Xu Z; Zhang TF; Wang YL
    World J Gastroenterol; 2015 Sep; 21(34):9853-62. PubMed ID: 26379392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma miRNAs as early biomarkers for detecting hepatocellular carcinoma.
    Wen Y; Han J; Chen J; Dong J; Xia Y; Liu J; Jiang Y; Dai J; Lu J; Jin G; Han J; Wei Q; Shen H; Sun B; Hu Z
    Int J Cancer; 2015 Oct; 137(7):1679-90. PubMed ID: 25845839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-128-3p suppresses hepatocellular carcinoma proliferation by regulating PIK3R1 and is correlated with the prognosis of HCC patients.
    Huang CY; Huang XP; Zhu JY; Chen ZG; Li XJ; Zhang XH; Huang S; He JB; Lian F; Zhao YN; Wu GB
    Oncol Rep; 2015 Jun; 33(6):2889-98. PubMed ID: 25962360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of micro-RNAs in hepatocellular carcinoma: from molecular biology to treatment.
    D'Anzeo M; Faloppi L; Scartozzi M; Giampieri R; Bianconi M; Del Prete M; Silvestris N; Cascinu S
    Molecules; 2014 May; 19(5):6393-406. PubMed ID: 24853455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison.
    Shen S; Lin Y; Yuan X; Shen L; Chen J; Chen L; Qin L; Shen B
    Sci Rep; 2016 Dec; 6():38311. PubMed ID: 27917899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small but Heavy Role: MicroRNAs in Hepatocellular Carcinoma Progression.
    Chen E; Xu X; Liu R; Liu T
    Biomed Res Int; 2018; 2018():6784607. PubMed ID: 29951542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of microRNAs and their potential diagnostic, therapeutic, and prognostic role in hepatocellular carcinoma.
    Zhou Y; Liu F; Ma C; Cheng Q
    J Clin Lab Anal; 2022 Oct; 36(10):e24673. PubMed ID: 36036748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma.
    Amr KS; Ezzat WM; Elhosary YA; Hegazy AE; Fahim HH; Kamel RR
    Gene; 2016 Jan; 575(1):66-70. PubMed ID: 26302751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma.
    Xu J; Li J; Zheng TH; Bai L; Liu ZJ
    Adv Clin Exp Med; 2016; 25(5):971-975. PubMed ID: 28028963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.
    Fang F; Chang RM; Yu L; Lei X; Xiao S; Yang H; Yang LY
    J Hepatol; 2015 Oct; 63(4):874-85. PubMed ID: 25998163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs as possible biomarkers for diagnosis and prognosis of hepatitis B- and C-related-hepatocellular-carcinoma.
    Fiorino S; Bacchi-Reggiani ML; Visani M; Acquaviva G; Fornelli A; Masetti M; Tura A; Grizzi F; Zanello M; Mastrangelo L; Lombardi R; Di Tommaso L; Bondi A; Sabbatani S; Domanico A; Fabbri C; Leandri P; Pession A; Jovine E; de Biase D
    World J Gastroenterol; 2016 Apr; 22(15):3907-36. PubMed ID: 27099435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma.
    Bronte F; Bronte G; Fanale D; Caruso S; Bronte E; Bavetta MG; Fiorentino E; Rolfo C; Bazan V; Di Marco V; Russo A
    Crit Rev Oncol Hematol; 2016 Jan; 97():312-21. PubMed ID: 26603462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of microRNAs in the main molecular pathways of hepatocellular carcinoma.
    Vasuri F; Visani M; Acquaviva G; Brand T; Fiorentino M; Pession A; Tallini G; D'Errico A; de Biase D
    World J Gastroenterol; 2018 Jul; 24(25):2647-2660. PubMed ID: 29991871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of sorafenib on lung metastasis in rats with hepatocellular carcinoma: the role of microRNAs.
    Shi Y; Huang A
    Tumour Biol; 2015 Nov; 36(11):8455-63. PubMed ID: 26026584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New kids on the block: diagnostic and prognostic microRNAs in hepatocellular carcinoma.
    Ji J; Wang XW
    Cancer Biol Ther; 2009 Sep; 8(18):1686-93. PubMed ID: 19901517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [microRNA: new diagnostic and therapeutic tools in liver disease?].
    Gougelet A; Colnot S
    Med Sci (Paris); 2013 Oct; 29(10):861-7. PubMed ID: 24148124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.